| アブストラクト | PURPOSE: Some evidence suggests no association between type 1a (T1a) selective alpha-blockers and hypotension-related adverse drug reactions (HR-ADRs), although safety concerns still exist. We sought to investigate the association of HR-ADRs with selective T1a blockers and identify at-risk groups. METHODS AND MATERIALS: We used disproportionality analysis to detect signals of HR-ADRs (dizziness, fainting, falls, and fractures) reported with selective T1a blocker use in VigiBase, a global database of individual case safety reports. Excluding duplicates, all reports were included (1967-2022). Significance was determined using lower bound 95% empiric Bayes estimator > 1; only then were reporting odds ratios (RORs) and 95% CIs reported. Subgroup analyses were stratified by sex, age (<65 and >/=65 years), and indication for men only (urinary stone disease [USD] and benign prostatic hyperplasia [BPH]). RESULTS: We identified 5963 reports of HR-ADRs with selective T1a blockers. Selective T1a blockers were significantly associated with HR-ADRs (ROR 1.46; 95% CI 1.42-1.49). In men, selective T1a blockers for USD were associated with increased risk of HR-ADRs (ROR 1.60; 95% CI 1.56-1.65), which only remained significant in the older subgroup (ROR 6.70; 95% CI 3.20-14.01). No association was found for BPH. In women, selective T1a blockers were associated with an increased risk of HR-ADRs (ROR 1.09; 95% CI 0.99-1.09). This was only significant in the younger subgroup (ROR 1.17; 95% CI 1.03-1.32). CONCLUSIONS: In older men with USD and younger women, selective T1a blockers were associated with higher risk of HR-ADRs, suggesting the need for continued monitoring in these populations. No signal was observed for men with BPH. |
|---|
| ジャーナル名 | Urology practice |
|---|
| Pubmed追加日 | 2025/2/7 |
|---|
| 投稿者 | Song, Jonathan J; Qian, Zhiyu Jason; Cho, Mansoo; Nguyen, David-Dan; Trinh, Quoc-Dien; Wollin, Daniel A |
|---|
| 組織名 | Boston University Chobanian and Avedisian School of Medicine, Boston,;Massachusetts.;Department of Urology, Brigham and Women's Hospital, Boston, Massachusetts.;Center for Surgery and Public Health, Brigham and Women's Hospital, Boston,;Institute of Health Policy, Management and Evaluation, University of Toronto,;Toronto, Ontario.;Division of Urology, University of Toronto, Toronto, Ontario. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/39918267/ |
|---|
